Neuropeptide research
Selank
Synthetic analogue of tuftsin with anxiolytic activity
VY-SEL-2608-01Tested 2026-08-19
Purchase options
Price
$65
AUD · GST inclusive · $6.50 per mg
Quantity
1
Same-day dispatch
Orders before 2pm AEST
Tracked express post
Australia Post, 1–3 business days
Discreet packaging
Plain, unbranded outer box
Description
Selank is a heptapeptide derived from the immunomodulatory tetrapeptide tuftsin, extended with a Pro-Gly-Pro tail for metabolic stability. Research examines its modulation of GABAergic transmission, BDNF expression and enkephalin degradation in anxiety and attention models.
Research notes
- Inhibits enkephalin-degrading enzymes in brain tissue assays
- Studied as a complementary neuropeptide alongside ACTH-fragment analogues
- Stable lyophilised form; reconstitute immediately before use
Research use only. This compound is supplied for in-vitro and laboratory research. It is not approved by the TGA or any regulatory body for human or veterinary use. Not for human consumption. Handle with appropriate laboratory precautions.
Specifications
- Purity (independent)
- 99.21%
- Molecular formula
- C33H57N11O9
- Molar mass
- 751.9 g/mol
- CAS number
- 129954-34-3
- Sequence
- TKPRPGP
- Form
- Lyophilised powder
- Storage
- −20 °C
- Batch
- VY-SEL-2608-01
- Last tested
- 2026-08-19